Asthma Clinical Trial
Official title:
The Effects of Core Stabilization Training on Dynamic Balance and Pulmonary Parameters Among Patients With Asthma: A Randomized Controlled Trial
| Verified date | November 2017 |
| Source | Yeditepe University |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
Objective: To investigate the effectiveness of core stabilization exercises combined with the
patient education program (AEP) and breathing exercises in patients with asthma.
Design: A randomized controlled study Setting: Chest diseases clinic of a university
hospital. Subjects: The study sample consists of 26-68 years old asthma patients who were
diagnosed at least 6 month prior to the study.
Interventions: All subjects were included in the asthma education program (AEP) and both
groups were trained for diaphragmatic and pursed lip breathing exercises (2times/wk. 6-week
duration at clinic). The core stabilization program was applied twice a week for a duration
of 6 weeks in TG.
Main Measures: Spirometry, maximum inspiratory pressure (MIP) and maximum expiratory pressure
(MEP), International Physical Activity Questionnaire Short Form (IPAQ), Hospital Anxiety and
Depression Scale(HADS), Asthma Quality of Life Questionnaire(AQOL), Six-minute walking
test(6MWT), Prokin PK200, Italy were used to evaluate feasibility of interventions.
| Status | Completed |
| Enrollment | 51 |
| Est. completion date | March 2016 |
| Est. primary completion date | January 2016 |
| Accepts healthy volunteers | No |
| Gender | Female |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - Participating to the study in a voluntary basis. - Being 18 years old and upper - Getting diagnosed with asthma at least 6 months before. Exclusion Criteria: - Having an asthma attack in last 2 weeks. - Having physical and/or mental disability. - Having visual, hearing and/or verbal impairments. |
| Country | Name | City | State |
|---|---|---|---|
| n/a | |||
| Lead Sponsor | Collaborator |
|---|---|
| Yeditepe University | Istanbul University |
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Maximum Inspiratory Pressure | The Micro Medical Micro RPM, England respiratory pressure meter was used to measure respiratory muscle strength | Six Weeks | |
| Primary | Functional Capacity Test | The Six Minute Walking Test was used to evaluate functional capacity of volunteers. 6MWT was performed on a 30 meter corridor in the clinic according to American Thoracic Society guidelines. Walking distance was calculated. | Six Weeks | |
| Primary | Forced vital capacity in 1 second (FEV1) | Medical International Research Spirodoc® Spiro, Italy brand named spirometry was used to evaluate pulmonary functions of volunteers. | Six Weeks | |
| Primary | Quality of life | Asthma Quality of Life Scale (AQOL) was utilized to assess quality of life of participants over two weeks prior to the interview which was validated for the Turkish population.l | Six Weeks | |
| Primary | Maximum Expiratory Pressure | The Micro Medical Micro RPM, England respiratory pressure meter was used to measure respiratory muscle strength | Six Weeks | |
| Primary | Functional Vital Capacity (FVC) | Medical International Research Spirodoc® Spiro, Italy brand named spirometry was used to evaluate pulmonary functions of volunteers. | Six Weeks | |
| Primary | Tiffeneau Ratio (FEV1/FVC) | Medical International Research Spirodoc® Spiro, Italy brand named spirometry was used to evaluate pulmonary functions of volunteers. | Six Weeks | |
| Primary | Forced Expiratory Flow from 25 % to 75 % of Vital Capacity (FEF25-75) | Medical International Research Spirodoc® Spiro, Italy brand named spirometry was used to evaluate pulmonary functions of volunteers. | Six Weeks | |
| Secondary | Physical Activity | International Physical Activity Questionnaire Short Form (IPAQ) was used to determine physical activity status.The total score of IPAQ is calculated by summation of the duration (in minutes) and frequency (days) of three physical activities. | Six Weeks | |
| Secondary | Depression level | The valid and reliable version of the Hospital Anxiety and Depression Scale (HADS) for the Turkish population was utilized to determine depression level. | Six Weeks | |
| Secondary | Anxiety level | The valid and reliable version of the Hospital Anxiety and Depression Scale (HADS) for the Turkish population was utilized to determine anxiety level. | Six Weeks | |
| Secondary | Dynamic balance | Dynamic balance alterations of the subjects were assessed by TechnoBody Prokin PK 200 (PK), Italy dynamic balance instrument. PK is a circular mobile balance assessment platform like conventional rocker board. PK transmits data from platform to the computer with a wireless transmitter and it can detect each single angular movement with a chip inside the platform. Additionally, PK has four different applicators (easy, medium, hard and rectangular) to place under the mobile platform. The bipedal position for 30 seconds with the easy applicator during the dynamic balance test was used. PK is connected to a computer; in this way each single movement is recorded by a computer in real time mode. | Six Weeks |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
| Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
| Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
| Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
| Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
| Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
| Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
| Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
| Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
| Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
| Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
| Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
| Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
| Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
| Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
| Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
| Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
| Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|